Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Sandoz Inc., priced at $4.2803 per ML under NDC 61314064705. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Sandoz Inc.NDC
61314064705
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050592On Market Since
1/2/2009
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 74.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2803 per ML |
|---|---|
| All-time high | $17.7355 (Apr 16, 2014) |
| All-time low | $3.7216 (Jul 17, 2024) |
| 52-week high | $4.7783 |
| 52-week low | $4.1809 |
| Median price | $14.1951 |
| Average price | $12.1918 |
| Largest weekly change | +49.3% (Nov 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Sandoz Inc., is $4.2803 per ML (NDC 61314064705), effective Jun 24, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 74.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $3.7216 (Jul 17, 2024) to a high of $17.7355 (Apr 16, 2014), with a median of $14.1951 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TOBRAMYCIN-DEXAMETH OPHTH SUSP, but none are currently priced below it.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 61314064705) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification